Par Pharmaceutical names new chief commercial officer

WOODCLIFF LAKE, N.J. — Par Pharmaceutical announced the appointment of Antonio R. Pera as CCO. In his new role, Pera will lead Par's newly integrated sales and marketing organization. He'll be instrumental in managing Par's relationships with major trade partners, the company said.

Pera joins the organization from JHP, which Par recently acquired. He has more 30 years of experience in the pharmaceutical industry, which, in addition to his time at JHP, also includes time in executive leadership at AmerisourceBergen Corp.

"Tony has enjoyed a distinguished career in the pharmaceutical industry, and we are very pleased to have him join the Par team," said Paul V. Campanelli, CEO of Par Pharmaceutical Companies. "He has a demonstrated expertise in the marketing, sales and distribution of generic drugs. We look forward to the leadership Tony will provide our commercial organization and the many contributions he will make to our company."  

Pera earned an MBA from DePaul University in 1984 and a B.S. in business administration from the University of Illinois, Champaign-Urbana in 1979.    


Login or Register to post a comment.